Home/Filings/4/0001077183-24-000071
4//SEC Filing

Harris Melody 4

Accession 0001077183-24-000071

CIK 0001077183other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 9:38 PM ET

Size

23.2 KB

Accession

0001077183-24-000071

Insider Transaction Report

Form 4
Period: 2024-05-11
Harris Melody
Chf Ops Off, Pres, Informatics
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-11+7,068110,023 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-117,06814,136 total
    Exercise: $0.00Common Stock (7,068 underlying)
  • Tax Payment

    Common Stock

    2024-05-11$14.86/sh1,722$25,589108,301 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $9.24Exp: 2030-01-01Common Stock (201,613 underlying)
    201,613
  • Stock Option (Right to Buy)

    Exercise: $19.65Exp: 2030-05-11Common Stock (39,683 underlying)
    39,683
  • Performance Stock Unit

    Exercise: $0.00From: 2026-05-11Common Stock (21,204 underlying)
    21,204
  • Stock Option (Right to Buy)

    Exercise: $13.96Exp: 2034-05-02Common Stock (19,984 underlying)
    19,984
  • Stock Option (Right to Buy)

    Exercise: $16.45Exp: 2034-02-23Common Stock (42,344 underlying)
    42,344
  • Performance Stock Unit

    Exercise: $0.00From: 2027-05-02Common Stock (11,939 underlying)
    11,939
  • Restricted Stock Unit

    Exercise: $0.00Common Stock (25,329 underlying)
    25,329
  • Restricted Stock Unit

    Exercise: $0.00Common Stock (11,939 underlying)
    11,939
  • Performance Stock Unit

    Exercise: $0.00From: 2027-02-23Common Stock (25,330 underlying)
    25,330
Footnotes (13)
  • [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
  • [F10]On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F11]On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F12]On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F13]On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
  • [F3]On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F4]Once vested, the shares of common stock are not subject to expiration.
  • [F5]On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F6]On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F7]On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
  • [F8]On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F9]On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001880847

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:38 PM ET
Size
23.2 KB